Point72 (Difc) LTD Biomarin Pharmaceutical Inc Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
A detailed history of Point72 (Difc) LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 27,758 shares of BMRN stock, worth $1.53 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
27,758
Previous 6,799
308.27%
Holding current value
$1.53 Million
Previous $447 Million
339.06%
% of portfolio
0.08%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$978 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$823 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$594 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...